429 related articles for article (PubMed ID: 29192179)
1. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models.
Eide PW; Bruun J; Lothe RA; Sveen A
Sci Rep; 2017 Nov; 7(1):16618. PubMed ID: 29192179
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
Sveen A; Bruun J; Eide PW; Eilertsen IA; Ramirez L; Murumägi A; Arjama M; Danielsen SA; Kryeziu K; Elez E; Tabernero J; Guinney J; Palmer HG; Nesbakken A; Kallioniemi O; Dienstmann R; Lothe RA
Clin Cancer Res; 2018 Feb; 24(4):794-806. PubMed ID: 29242316
[No Abstract] [Full Text] [Related]
3. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.
Linnekamp JF; Hooff SRV; Prasetyanti PR; Kandimalla R; Buikhuisen JY; Fessler E; Ramesh P; Lee KAST; Bochove GGW; de Jong JH; Cameron K; Leersum RV; Rodermond HM; Franitza M; Nürnberg P; Mangiapane LR; Wang X; Clevers H; Vermeulen L; Stassi G; Medema JP
Cell Death Differ; 2018 Mar; 25(3):616-633. PubMed ID: 29305587
[TBL] [Abstract][Full Text] [Related]
4. A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
Piskol R; Huw L; Sergin I; Kljin C; Modrusan Z; Kim D; Kljavin N; Tam R; Patel R; Burton J; Penuel E; Qu X; Koeppen H; Sumiyoshi T; de Sauvage F; Lackner MR; de Sousa E Melo F; Kabbarah O
Clin Cancer Res; 2019 Jul; 25(14):4431-4442. PubMed ID: 31004000
[TBL] [Abstract][Full Text] [Related]
5. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype.
Kwon Y; Park M; Jang M; Yun S; Kim WK; Kim S; Paik S; Lee HJ; Hong S; Kim TI; Min B; Kim H
Oncotarget; 2017 Jun; 8(24):39367-39381. PubMed ID: 28455965
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting.
Morris JS; Luthra R; Liu Y; Duose DY; Lee W; Reddy NG; Windham J; Chen H; Tong Z; Zhang B; Wei W; Ganiraju M; Broom BM; Alvarez HA; Mejia A; Veeranki O; Routbort MJ; Morris VK; Overman MJ; Menter D; Katkhuda R; Wistuba II; Davis JS; Kopetz S; Maru DM
Clin Cancer Res; 2021 Jan; 27(1):120-130. PubMed ID: 33109741
[TBL] [Abstract][Full Text] [Related]
8. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
Fessler E; Jansen M; De Sousa E Melo F; Zhao L; Prasetyanti PR; Rodermond H; Kandimalla R; Linnekamp JF; Franitza M; van Hooff SR; de Jong JH; Oppeneer SC; van Noesel CJ; Dekker E; Stassi G; Wang X; Medema JP; Vermeulen L
Oncogene; 2016 Nov; 35(46):6026-6037. PubMed ID: 27157610
[TBL] [Abstract][Full Text] [Related]
9. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
[TBL] [Abstract][Full Text] [Related]
10. Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.
Eide PW; Moosavi SH; Eilertsen IA; Brunsell TH; Langerud J; Berg KCG; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA; Sveen A
NPJ Genom Med; 2021 Jul; 6(1):59. PubMed ID: 34262039
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155.
Zhan T; Faehling V; Rauscher B; Betge J; Ebert MP; Boutros M
Int J Cancer; 2021 Apr; 148(8):1948-1963. PubMed ID: 33186476
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtyping improves prognostication of Stage 2 colorectal cancer.
Purcell RV; Schmeier S; Lau YC; Pearson JF; Frizelle FA
BMC Cancer; 2019 Nov; 19(1):1155. PubMed ID: 31775679
[TBL] [Abstract][Full Text] [Related]
13. classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes.
Quinn GP; Sessler T; Ahmaderaghi B; Lambe S; VanSteenhouse H; Lawler M; Wappett M; Seligmann B; Longley DB; McDade SS
BMC Bioinformatics; 2022 Mar; 23(1):114. PubMed ID: 35361119
[TBL] [Abstract][Full Text] [Related]
14. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
Eilertsen IA; Moosavi SH; Strømme JM; Nesbakken A; Johannessen B; Lothe RA; Sveen A
Cancer Lett; 2020 Jan; 469():246-255. PubMed ID: 31678167
[TBL] [Abstract][Full Text] [Related]
15. Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer.
Rashid NU; Peng XL; Jin C; Moffitt RA; Volmar KE; Belt BA; Panni RZ; Nywening TM; Herrera SG; Moore KJ; Hennessey SG; Morrison AB; Kawalerski R; Nayyar A; Chang AE; Schmidt B; Kim HJ; Linehan DC; Yeh JJ
Clin Cancer Res; 2020 Jan; 26(1):82-92. PubMed ID: 31754050
[TBL] [Abstract][Full Text] [Related]
16. Identification of modules and functional analysis in CRC subtypes by integrated bioinformatics analysis.
Chen R; Sugiyama A; Seno H; Sugimoto M
PLoS One; 2019; 14(8):e0221772. PubMed ID: 31469863
[TBL] [Abstract][Full Text] [Related]
17. TNK2 as a key drug target for the treatment of metastatic colorectal cancer.
Qi L; Ding Y
Int J Biol Macromol; 2018 Nov; 119():48-52. PubMed ID: 30036625
[TBL] [Abstract][Full Text] [Related]
18. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines.
Schlicker A; Beran G; Chresta CM; McWalter G; Pritchard A; Weston S; Runswick S; Davenport S; Heathcote K; Castro DA; Orphanides G; French T; Wessels LF
BMC Med Genomics; 2012 Dec; 5():66. PubMed ID: 23272949
[TBL] [Abstract][Full Text] [Related]
19. Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer.
Dunne PD; McArt DG; Bradley CA; O'Reilly PG; Barrett HL; Cummins R; O'Grady T; Arthur K; Loughrey MB; Allen WL; McDade SS; Waugh DJ; Hamilton PW; Longley DB; Kay EW; Johnston PG; Lawler M; Salto-Tellez M; Van Schaeybroeck S
Clin Cancer Res; 2016 Aug; 22(16):4095-104. PubMed ID: 27151745
[TBL] [Abstract][Full Text] [Related]
20. Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.
Adam RS; Poel D; Ferreira Moreno L; Spronck JMA; de Back TR; Torang A; Gomez Barila PM; Ten Hoorn S; Markowetz F; Wang X; Verheul HMW; Buffart TE; Vermeulen L
Mol Oncol; 2022 Jul; 16(14):2693-2709. PubMed ID: 35298091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
